Cordis Announces FDA Clearance of the ADROIT™ Guiding Catheter

  Cordis Announces FDA Clearance of the ADROIT™ Guiding Catheter

Business Wire

FREMONT, Calif. -- June 12, 2013

Cordis Corporation today announced it has received clearance from the Food and
Drug Administration of its latest innovation in guiding catheters: the
ADROIT^TM 6F Guiding Catheter.

“The new ADROIT^TM Guiding Catheter, allows physicians to have more options
for treating a wide range of challenging cases. It accommodates easier
advancement of devices with its 0.072’ diameter, the largest inner diameter of
any guiding catheter in the U.S., while providing better support and control
at the same time. These features enhance treatment options for physicians,
including the treatment of cases with complex lesions and those to be
conducted using the radial approach,” said Celine Martin, Worldwide President,
Cordis Corporation.

The ADROIT^TM Catheter’s innovative hybrid braid wire technology not only
enables the production of a guide catheter with the largest lumen size on the
U.S. market today, it also facilitates better control and back up support. In
addition, the new innovative design incorporating a flexible distal segment
and soft longer tip allows atraumatic placement and stability. The ADROIT^TM
Guiding Catheter provides a wide range of shapes, including extra back-up
shapes and radial specific shapes to support treatment needs of various
coronary anatomies.

“Our vision at Cordis is to transform cardiovascular care, a field in which
incredible progress has been made over the last decade, but one in which much
more remains to be done. We are excited for the launch of our new ADROIT^TM
Guiding Catheter as it complements our guide catheter portfolio with its
technological and design advances. We will continue to deliver innovative
solutions that save lives and improve the quality of life for people around
the world,” concluded Martin.

About Cordis Corporation

Cordis Corporation, part of the Johnson & Johnson Family of Companies, is a
worldwide leader in the development and manufacture of interventional vascular
technology. Through the company's innovation, research and development, Cordis
partners with physicians worldwide to treat millions of patients who suffer
from vascular disease. More information about Cordis Corporation can be found
at www.cordis.com (this site is intended for U.S. visitors).

Contact:

Media:
For Cordis Corporation
Sandy Pound, 908-432-2829
spound@its.jnj.com
 
Press spacebar to pause and continue. Press esc to stop.